Article info
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - anti-TNF therapy
THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch
Citation
THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch
Publication history
- First published June 10, 2014.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions